Literature DB >> 33759020

Hemoglobinuria for the early identification of STEC-HUS in high-risk children: data from the ItalKid-HUS Network.

Valentina Capone1, Maria Cristina Mancuso2, Giacomo Tamburini2, Giovanni Montini2,3, Gianluigi Ardissino2.   

Abstract

Hemolytic uremic syndrome (HUS) represents one of the main causes of severe acute kidney injury in children. The most frequent form of HUS is caused by Shiga toxin-2 (Stx2)-producing Escherichia coli. Hemoglobinuria and hematuria are markers of glomerular damage, but their use has never been validated in HUS. We retrospectively analyzed the presence of hemoglobinuria/urinary red blood cells (RBCs) in children with Stx2-positive bloody diarrhea (BD) or with already ongoing STEC-HUS with the aim of validating its role in early identifying HUS. We reviewed all the pediatric patients with Stx2+ BD (group 1) and with ongoing HUS (group 2) referred to our center from 2010 to 2019. A total of 100 children were eligible for the study. In group 1, 22 patients showed hemoglobinuria/hematuria, while 41 remained negative. In 15/22 positive patients (68.2%), blood tests ruled in HUS, while in 7 (31.8%), HUS was excluded. Among the 41 patients persistently negative for hemoglobinuria/hematuria, no one developed HUS. The 37 STEC-HUS children (group 2) all had hemoglobinuria/RBCs at admission.
Conclusion: Hemoglobinuria/hematuria for the diagnosis of HUS in children with Stx2+ BD showed a sensitivity of 100% and a specificity of 85%. We strongly recommend patients with BD carrying Stx2 in stools to be closely monitored with urine dipstick/urinalysis to early identify HUS. What is Known • Children with bloody diarrhea secondary to Shiga toxin 2 are at high risk of hemolytic uremic syndrome, thus have to be carefully monitored for the development of the disease, in order to early be hospitalized and treated. What is New • Urine dipstick for hemoglobinuria can be used as an easy, inexpensive, and repeatable tool to early diagnose children with bloody diarrhea secondary to Shiga toxin 2 to have developed hemolytic uremic syndrome, with no risk of false-negative results.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bloody diarrhea; Hemolytic uremic syndrome; STEC-HUS; Shiga toxin

Year:  2021        PMID: 33759020     DOI: 10.1007/s00431-021-04016-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Time to change the definition of hemolytic uremic syndrome.

Authors:  Gianluigi Ardissino; Ilaria Possenti; Francesca Tel; Sara Testa; Fabio Paglialonga
Journal:  Eur J Intern Med       Date:  2013-12-21       Impact factor: 4.487

2.  A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network.

Authors:  Gianluigi Ardissino; Francesca Tel; Sara Testa; Fabio Paglialonga; Selena Longhi; Laura Martelli; Silvia Consolo; Damiano Picicco; Antonella Dodaro; Laura Daprai; Rosaria Colombo; Milena Arghittu; Michela Perrone; Giovanna Chidini; Stefano Scalia Catenacci; Isabella Cropanese; Dario Consonni
Journal:  Eur J Pediatr       Date:  2018-08-10       Impact factor: 3.183

3.  Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2012-04-03       Impact factor: 3.714

Review 4.  Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.

Authors:  P Ruggenenti; M Noris; G Remuzzi
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

5.  An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.

Authors:  Sebastian Loos; Thurid Ahlenstiel; Brigitta Kranz; Hagen Staude; Lars Pape; Christoph Härtel; Udo Vester; Laura Buchtala; Kerstin Benz; Bernd Hoppe; Ortraud Beringer; Martin Krause; Dominik Müller; Martin Pohl; Johanna Lemke; Georg Hillebrand; Martin Kreuzer; Jens König; Marianne Wigger; Martin Konrad; Dieter Haffner; Jun Oh; Markus J Kemper
Journal:  Clin Infect Dis       Date:  2012-06-05       Impact factor: 9.079

6.  Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.

Authors:  Gianluigi Ardissino; Ilaria Possenti; Chiara Vignati; Laura Daprai; Valentina Capone; Maurizio Brigotti; Mario Vittorio Luini; Dario Consonni; Giovanni Montini
Journal:  Pediatr Nephrol       Date:  2020-07-30       Impact factor: 3.714

7.  Predictors of fatality in postdiarrheal hemolytic uremic syndrome.

Authors:  Robert S Oakes; Richard L Siegler; Markham A McReynolds; Theodore Pysher; Andrew T Pavia
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

8.  Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network.

Authors:  Gianluigi Ardissino; Stefania Salardi; Elisa Colombo; Sara Testa; Nicolò Borsa-Ghiringhelli; Fabio Paglialonga; Valentina Paracchini; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Cristina Felice Civitillo; Stefano Sardini; Rossella Ceruti; Carlo Baldioli; Paola Tommasi; Luciana Parola; Fiorella Russo; Silvana Tedeschi
Journal:  Eur J Pediatr       Date:  2015-10-24       Impact factor: 3.183

Review 9.  Hemolytic uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2005-02-23       Impact factor: 10.121

Review 10.  Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Johanna Scheiring; Sharon P Andreoli; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2008-08-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.